NEW YORK (GenomeWeb News) – NuMedii announced today that it has raised $3.5 million in a Series A funding round led by Claremont Creek Ventures and Lightspeed Venture Partners with participation from Life Science Angels and others.

NuMedii said that it will use the funding to further develop its proprietary technology and prepare its first three internal drug development programs for clinical testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.